Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$104.51 USD

104.51
3,425,759

+0.46 (0.44%)

Updated Dec 8, 2023 04:00 PM ET

After-Market: $104.52 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.96%
2Buy17.61%
3Hold8.96%
4Sell4.80%
5Strong Sell2.32%
S&P50010.64%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (140 out of 251)

Industry: Medical - Products

Better trading starts here.

Balance Sheet

Research for ABT

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Abbott Laboratories falls in the month of December.

All items in Millions except Per Share data.

12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Assets          
Cash & Equivalents 10,170 10,249 7,148 4,140 4,086
Receivables 6,218 6,487 6,414 5,425 5,182
Notes Receivable 0 0 0 0 0
Inventories 6,173 5,157 5,012 4,316 3,796
Other Current Assets 2,663 2,346 1,867 1,786 1,568
Total Current Assets 25,224 24,239 20,441 15,667 14,632
Net Property & Equipment 9,162 8,959 9,029 8,038 7,563
Investments & Advances 766 816 821 883 897
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 6,033 5,212 3,729 3,079 1,868
Intangibles 33,253 35,970 38,528 40,220 42,196
Deposits & Other Assets 0 0 0 0 17
Total Assets 74,438 75,196 72,548 67,887 67,173
Liabilities & Shareholders Equity 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Notes Payable 0 0 213 201 200
Accounts Payable 4,607 4,408 3,946 3,252 2,975
Current Portion Long-Term Debt 2,251 754 7 1,277 7
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 7,401 6,806 6,581 5,272 4,962
Income Taxes Payable 343 306 362 226 305
Other Current Liabilities 887 831 798 635 563
Total Current Liabilities 15,489 13,105 11,907 10,863 9,012
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 14,522 17,296 18,527 16,661 19,359
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 7,522 8,771 9,111 9,062 8,080
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 37,533 39,172 39,545 36,586 36,451
Shareholders Equity 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Preferred Stock 0 0 0 0 0
Common Stock (Par) 24,709 24,470 24,145 23,853 23,512
Capital Surplus 0 0 0 0 0
Retained Earnings 35,257 31,528 27,627 25,847 24,560
Other Equity -7,832 -8,152 -8,727 -8,252 -7,388
Treasury Stock 15,229 11,822 10,042 10,147 9,962
Total Shareholder's Equity 36,905 36,024 33,003 31,301 30,722
Total Liabilities & Shareholder's Equity 74,438 75,196 72,548 67,887 67,173
Total Common Equity 36,905 36,024 33,003 31,301 30,722
Shares Outstanding 1,743.50 1,768.20 1,772.30 1,768.40 1,756.30
Book Value Per Share 21.17 20.37 18.62 17.70 17.49

Fiscal Year End for Abbott Laboratories falls in the month of December.

All items in Millions except Per Share data.

9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Assets          
Cash & Equivalents 7,047 8,155 9,532 10,170 9,907
Receivables 6,499 6,172 6,020 6,218 6,408
Notes Receivable 0 0 0 0 0
Inventories 6,650 6,871 6,673 6,173 5,734
Other Current Assets 2,468 2,307 2,152 2,663 2,796
Total Current Assets 22,664 23,505 24,377 25,224 24,845
Net Property & Equipment 9,552 9,449 9,282 9,162 8,689
Investments & Advances 788 799 776 766 764
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 6,527 6,509 6,426 6,033 5,369
Intangibles 32,559 33,092 32,933 33,253 33,134
Deposits & Other Assets 0 0 0 0 0
Total Assets 72,090 73,354 73,794 74,438 72,801
Liabilities & Shareholders Equity 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Notes Payable 0 0 0 0 0
Accounts Payable 3,961 4,211 4,167 4,607 4,133
Current Portion Long-Term Debt 1,051 2,284 2,285 2,251 1,117
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 6,826 6,696 6,856 7,401 6,901
Income Taxes Payable 318 273 334 343 394
Other Current Liabilities 886 886 888 887 820
Total Current Liabilities 13,042 14,350 14,530 15,489 13,365
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 14,477 14,562 14,615 14,522 15,297
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 6,877 7,417 7,522 8,255
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 34,396 35,950 36,562 37,533 36,917
Shareholders Equity 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Preferred Stock 0 0 0 0 0
Common Stock (Par) 24,727 24,612 24,488 24,709 24,560
Capital Surplus 0 0 0 0 0
Retained Earnings 36,920 36,355 35,868 35,257 35,115
Other Equity -8,267 -7,841 -7,817 -7,832 -9,236
Treasury Stock 15,686 15,722 15,307 15,229 14,555
Total Shareholder's Equity 37,694 37,404 37,232 36,905 35,884
Total Liabilities & Shareholder's Equity 72,090 73,354 73,794 74,438 72,801
Total Common Equity 37,694 37,404 37,232 36,905 35,884
Shares Outstanding 1,736.00 1,735.30 1,738.90 1,743.50 1,743.50
Book Value Per Share 21.71 21.55 21.41 21.17 20.58